Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Immuneering Corp Cl A (IMRX)

Immuneering Corp Cl A (IMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Emerging Oncology Breakthroughs Signal Opportunity Despite Research Funding Crunch BayStreet.ca - Wed Jul 16, 2:42PM CDT

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – Budget cuts are on the horizon for funding scientific research, and if supported by Congress, the development...

ONCY : 1.3200 (+5.60%)
CTMX : 2.38 (-0.42%)
NUVB : 2.24 (+0.45%)
IMRX : 4.30 (+8.59%)
ONC.TO : 1.78 (+4.71%)
CRDF : 4.45 (+0.68%)
Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up Newswire.ca - Thu Jul 10, 8:20AM CDT

/CNW/ -- USA News Group News Commentary – Cancer rates are rising everywhere, but more dramatically in some places. According to a new analysis of CDC data,...

ONCY : 1.3200 (+5.60%)
CLDI : 0.6159 (-2.58%)
KZIA : 10.27 (+0.79%)
NUVB : 2.24 (+0.45%)
IMRX : 4.30 (+8.59%)
ONC.TO : 1.78 (+4.71%)
KZA.AX : 0.080 (+9.59%)
Immuneering Granted U.S. Composition of Matter Patent for Highly Differentiated Cancer Drug Candidate Atebimetinib GlobeNewswire - Wed Jul 9, 7:00AM CDT

IMRX : 4.30 (+8.59%)
Why Early-Onset Cancers Are Alarming Researchers—and What It Means for Investors BayStreet.ca - Mon Jun 30, 8:53AM CDT

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – Baystreet.ca News Commentary – The current landscape of oncology is a mixed bag of results, with optimism coming from a decrease in US...

ONCY : 1.3200 (+5.60%)
NVCR : 16.21 (-2.29%)
IMAB : 2.16 (+0.47%)
IMRX : 4.30 (+8.59%)
ONC.TO : 1.78 (+4.71%)
PRPH : 0.3734 (+0.38%)
With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology Newswire.ca - Fri Jun 20, 8:21AM CDT

/CNW/ -- USA News Group News Commentary – The costs of cancer drugs is skyrocketing, according to a recent report from Bloomberg. Analysts at Nova One Advisor...

ONCY : 1.3200 (+5.60%)
RLAY : 3.65 (+0.27%)
INTS : 0.3335 (+2.52%)
GRAL : 35.92 (-1.88%)
IMRX : 4.30 (+8.59%)
ONC.TO : 1.78 (+4.71%)
Immuneering Reports Positive Overall Survival Data for Atebimetinib (IMM-1-104) from Ongoing Phase 2a Trial in First-Line Pancreatic Cancer Patients GlobeNewswire - Tue Jun 17, 5:00AM CDT

IMRX : 4.30 (+8.59%)
Immuneering to Provide Updates from Phase 2a Clinical Trial of IMM-1-104 in First-Line Pancreatic Cancer Patients on Tuesday, June 17, 2025 GlobeNewswire - Mon Jun 16, 7:00AM CDT

IMRX : 4.30 (+8.59%)
Immuneering to Present at the Jefferies Global Healthcare Conference GlobeNewswire - Thu May 29, 7:00AM CDT

IMRX : 4.30 (+8.59%)
Immuneering Reports First Quarter 2025 Financial Results and Provides Business Updates GlobeNewswire - Mon May 5, 3:05PM CDT

IMRX : 4.30 (+8.59%)
Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference GlobeNewswire - Wed Apr 2, 7:00AM CDT

IMRX : 4.30 (+8.59%)

Barchart Exclusives

Robinhood Keeps Hitting New Highs. How Should You Play HOOD Stock Here? Barchart - Thu Jul 17, 6:50PM CDT
With Robinhood soaring to new highs in 2025, should investors chase the momentum or wait for a better entry point? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot